Uncovering the mechanism of resveratrol in the treatment of asthma: a network pharmacology approach with molecular docking and experimental validation

Uncovering the mechanism of resveratrol in the treatment of asthma: a network pharmacology approach with molecular docking and experimental validation

BackgroundEvidence for the benefits of resveratrol (Res) in the treatment of asthma is progressively accumulating. However, the full spectrum of its molecular targets and the precise mechanisms remain incompletely characterized.MethodTargets of Res were obtained from Swiss Target Prediction, TCMCP,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Li Chunxiao, Hou Xin, Liu Bowen, Sun Bingqing, Zhou Mengqi, Zhang Shuwen, Zhang Jingyuan, Lin Jiangtao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Pharmacology
Subjects:	asthma resveratrol network pharmacology molecular docking airway inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1596737/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacological Mechanisms and Therapeutic Potential of Resveratrol in Rheumatoid Arthritis
by: Liu L, et al.
Published: (2025-07-01)

Identification of components in scorpion and centipede traditional Chinese medicine formulations with potentially beneficial actions in asthma: network pharmacology and molecular docking
by: Yi-Ren Chen, et al.
Published: (2025-07-01)

Experimental and computational insights into the therapeutic mechanisms of resveratrol in a Drosophila α-synuclein model of Parkinson’s disease
by: Amos Olalekan Abolaji, et al.
Published: (2025-05-01)

Integration of network pharmacology and experimental validation to explore the pharmacological mechanism of andrographolide against asthma
by: Qian Yu, et al.
Published: (2025-04-01)

Glycosylation in T2 high and Th17 Asthma: A Narrative Review
by: Yuan X, et al.
Published: (2025-04-01)

Airway inflammation, bronchial hyperresponsiveness, and anti-asthma therapy responses in cough variant asthma and classic asthma with FEV1% ≥80% predicted
by: Xue Zhang, et al.
Published: (2025-04-01)

Corrigendum: Investigating the mechanisms of resveratrol in the treatment of gouty arthritis through the integration of network pharmacology and metabolics
by: Xiaomin Xu, et al.
Published: (2025-02-01)

Research progress on free fatty acid receptors and bronchial asthma
by: Fangxin Cao, et al.
Published: (2024-09-01)

Inhibitory Effects of Phellodendri Cortex Against Airway Inflammation and Hyperresponsiveness in Ovalbumin-Induced Murine Asthma Model
by: Seong-Kyeom Kim, et al.
Published: (2025-04-01)

Prediction of drug-drug plasma protein binding interactions of resveratrol in combination with celecoxib and leflunomide by molecular docking combined with an ultrafiltration technique
by: Zhou Peng, et al.
Published: (2020-03-01)

Exacerbation of asthma and neutrophil-dominated airway inflammation in patients with cold-induced airway hyperresponsiveness
by: A. B. Pirogov, et al.
Published: (2021-07-01)

In silico approach in the development of structural analogues of resveratrol with improved distribution in the central nervous system
by: Mitrović Darko, et al.
Published: (2024-01-01)

Targeted Biologic Therapies in Severe Asthma: Mechanisms, Biomarkers, and Clinical Applications
by: Renata Maria Văruț, et al.
Published: (2025-07-01)

Comparative Analysis of ICS Combined with LABA versus Addition of Omalizumab on Transcriptomic Expression Profiles in Patients with Allergic Asthma
by: Liang YR, et al.
Published: (2025-06-01)

Identification of the Role of Mume fructus in Treating Nocturnal Asthma Based on Network Pharmacology and In vitro Investigation
by: Ling-Ling Tang, et al.
Published: (2024-12-01)

Combining Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and Experimental Validation to Uncover the Efficacy and Mechanisms of Si-Miao-Yong-An Decoction in Diabetic Wound Healing
by: Zhang S, et al.
Published: (2025-03-01)

Upregulated Hexokinase-2 in Airway Epithelium Regulates Apoptosis and Drives Inflammation in Asthma via Peptidylprolyl Isomerase F
by: Zhen Tian, et al.
Published: (2025-07-01)

Relationship between fractional exhaled nitric oxide, asthma control test, and spirometry measurement in individuals with asthma receiving treatment
by: Arthana Kanagaraj, et al.
Published: (2025-07-01)

The impact of phthalates on asthma and chronic obstructive pulmonary disease: a comprehensive analysis based on network toxicology and molecular docking
by: Ren Li, et al.
Published: (2025-03-01)

Yangke powder alleviates OVA-induced allergic asthma by inhibiting the PI3K/AKT/NF-κB signaling pathway
by: Xueyan Li, et al.
Published: (2025-05-01)

Resveratrol-loaded cumin seed oil nanoemulsion ameliorates neurodegeneration in mice by inhibiting apoptosis, inflammation, and oxidative DNA damage
by: Shaymaa Eissa, et al.
Published: (2024-10-01)

Is Exclusive Small Airway Asthma a Possibility?
by: Russell J. Hopp
Published: (2024-09-01)

The updated evidence of pirfenidone treated silicosis based on network pharmacology, molecular docking and experimental validation
by: Sirong Chang, et al.
Published: (2025-05-01)

The Mechanisms and Therapeutic Implications of PI3K Signaling in Airway Inflammation and Remodeling in Asthma
by: Song B, et al.
Published: (2025-03-01)

The potential effect of gut microbiota on the secretion of selected cytokines by human cells in vitro
by: Paulina Natalia Kopa-Stojak, et al.
Published: (2025-05-01)

Dietary resveratrol alleviates liver and intestinal injury in ducks under cage rearing system
by: Yong Tian, et al.
Published: (2025-08-01)

Investigation of the mechanistic impact of CBL0137 on airway remodeling in asthma
by: Zhiheng Huang, et al.
Published: (2025-03-01)

Periostin as a Biomarker of Bronchial Asthma
by: Natalia V. Shakhova
Published: (2020-01-01)

Combining network pharmacology and molecular docking to explore the pharmacological mechanism of Codonopsis Radix.-Hedysarum Multijugum Maxim.-Atractylodes Macrocephala Koidz. in treating lung cancer
by: Bin He, et al.
Published: (2025-02-01)

Non-Coding RNAs in Asthma: Regulators of Eosinophil Biology and Airway Inflammation
by: Eglė Vasylė, et al.
Published: (2025-07-01)

The Role of Physical Activity in Asthma Outcomes: A Review of Recent Studies
by: Jakub Mikszta, et al.
Published: (2025-04-01)

Network Pharmacology and Molecular Docking Analysis of Chrysoeriol for Alzheimer’s Disease
by: D Hariharasudhan, et al.
Published: (2025-01-01)

Network pharmacology and molecular docking reveal the potential inner mechanism between sensitive skin and hyperpigmentation
by: Jianhua Zhang, et al.
Published: (2025-03-01)

Analyzing the mechanism of rhubarb in the treatment of cervical cancer based on network pharmacology and molecular docking technology
by: Yingying Xu, et al.
Published: (2025-08-01)

Kiss1 receptor knockout exacerbates airway hyperresponsiveness and remodeling in a mouse model of allergic asthma
by: Nilesh Sudhakar Ambhore, et al.
Published: (2024-10-01)

Resveratrol-driven macrophage polarization: unveiling mechanisms and therapeutic potential
by: Panting Wang, et al.
Published: (2025-01-01)

Identification of metabolites from the gut microbiota in hypertension via network pharmacology and molecular docking
by: Wenjie Zhang, et al.
Published: (2024-10-01)

Assessment of functional tests on determining resistance of respiratory tract in patients with bronchial asthma, COPD and their combination.
by: K. V. Nazarenko, et al.
Published: (2017-10-01)

Increased expression of CSF1 in patients with eosinophilic asthma
by: Lijuan Du, et al.
Published: (2023-05-01)

Specificities of small airways dysfunction development in patients with mild asthma
by: Elena E. Mineeva, et al.
Published: (2021-03-01)